NICE drug reviews terminated when manufacturers fail to submit evidence (PDF 35 KB)
History
Documents created during the development process.
Background information
Archive: Draft scope
-
Archive: Draft scope
-
Glioma (recurrent) - carmustine implants - response to comments on the scope
-
Glioma (recurrent) - carmustine implants - response to comments on the scope
-
Glioma (recurrent) - carmustine implants - response to comments on the scope (PDF 61 KB)
Glioma (recurrent) - carmustine implants - response to comments on the provisional matrix
-
Glioma (recurrent) - carmustine implants - response to comments on the provisional matrix
-
Glioma (recurrent) - carmustine implants: response to consultee and commentator comments on provisional matrix
-
Glioma (recurrent) - carmustine implants: response to consultee and commentator comments on provisional matrix
-
Glioma (recurrent) - carmustine implants: Institute's response table to comments on scope
-
Glioma (recurrent) - carmustine implants: Institute's response table to comments on scope
-
Glioma (recurrent) - carmustine implants - response to comments on the scope (PDF 61 KB)
Glioma (recurrent) - carmustine implants: final matrix
-
Glioma (recurrent) - carmustine implants: final matrix
-
Glioma (recurrent) - carmustine implants: final matrix (PDF 39 KB)
Glioma (recurrent) - carmustine implants: final scope
-
Glioma (recurrent) - carmustine implants: final scope
-
Glioma (recurrent) - carmustine implants - response to comments on the scope (PDF 61 KB)